Expensify (EXFY) Form 144: 1,387 Shares Proposed Sale ($2,385)
Expensify, Inc. (EXFY) Rule 144 notice shows a proposed sale of 1,387 Class A common shares through Morgan Stanley Smith Barney on 08/20/2025 with an aggregate market value of $2,385.64.
Rhea-AI Filing Summary
Expensify, Inc. (EXFY) Rule 144 notice shows a proposed sale of 1,387 Class A common shares through Morgan Stanley Smith Barney on 08/20/2025 with an aggregate market value of $2,385.64. The filing reports the shares were acquired on 08/19/2025 from Expensify, Inc. as an SPMP contribution and paid as compensation. It also discloses three prior sales by the same beneficial owner in the past three months: 821 shares on 05/30/2025 for $1,822.62, 4,068 shares on 06/17/2025 for $9,275.04, and 1,869 shares on 06/20/2025 for $4,149.18. The filing states there is no known undisclosed material adverse information.
Positive
- Compliance disclosure appears complete: broker, acquisition method, payment nature, planned sale date and past three months' sales are all reported
- Transaction size is immaterial relative to the reported outstanding shares (1,387 vs 80,549,275)
Negative
- None.
Insights
TL;DR: Routine Form 144 notice for a small number of shares acquired as compensation and scheduled for resale through a broker on a stated date.
The filing documents a standard Rule 144 notice: 1,387 Class A shares acquired 08/19/2025 via an SPMP contribution and designated for sale on 08/20/2025 through Morgan Stanley Smith Barney. The aggregate market value reported is $2,385.64, a de minimis amount relative to the issuer's outstanding shares of 80,549,275. The filing also discloses recent dispositions by the same beneficial owner totaling 6,758 shares across three transactions, with gross proceeds documented. This appears procedural to comply with resale notice requirements and includes the required certification about undisclosed material information.
TL;DR: Filing reflects insider/affiliate sales activity and compliance with Rule 144 documentation; amounts are immaterial to cap table.
The submission lists the broker, planned sale date, acquisition details (SPMP contribution from the issuer), and the payment as compensation. The disclosed outstanding share count (80,549,275) provides context showing the proposed sale and recent sales are immaterial to overall equity. The statement attesting to absence of undisclosed material adverse information is present, as required. No other governance actions or material corporate events are reported in this notice.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 for Expensify, Inc. (EXFY) report?
Does the filing disclose recent sales by the same person?
Who is the broker handling the proposed sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.